Hilltop National Bank’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Hilltop National Bank’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$7.88K	Hold	50	–	–	﹤0.01%	670
2026 Q2	$7.91K	Hold	50	–	–	﹤0.01%	693
2026 Q1	$6.39K	Hold	50	–	–	﹤0.01%	697
2025 Q4	$6.1K	Hold	50	–	–	﹤0.01%	690
2025 Q3	$5.01K	Hold	50	–	–	﹤0.01%	708
2025 Q2	$4.15K	Buy	+50	New	+$3.99K	﹤0.01%	711
2024 Q4	$4.5K	Hold	50	–	–	﹤0.01%	695
2024 Q3	$4.94K	Hold	50	–	–	﹤0.01%	730
2024 Q2	$4.64K	Hold	50	–	–	﹤0.01%	723
2024 Q1	$4.75K	Buy	+50	New	+$4.64K	﹤0.01%	694

Other funds holding XBI

MIRAE ASSET SECURITIES (USA) INC. New York $3.57B AUM 26.78% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

EWM

Edge Wealth Management New York $666M AUM 17.64% 1-Year Est. Return

LHWM

Lake Hills Wealth Management Austin, Texas $218M AUM 31.66% 1-Year Est. Return

AIC

Ayalon Insurance Company Ramat Gan, Israel $1.2B AUM 25.57% 1-Year Est. Return

MWA

MFA Wealth Advisors Pittsburgh, Pennsylvania $589M AUM 19.71% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Fiduciary Alliance Greenville, South Carolina $1.33B AUM 15.58% 1-Year Est. Return

MAM

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

Fulcrum Capital Seattle, Washington $525M AUM 23.04% 1-Year Est. Return

Hilltop National Bank's XBI Position: Q3 2026 in Review

Hilltop National Bank held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 50 shares worth $7.88K. The position accounts for ﹤0.01% of the portfolio, ranked #670.

Hilltop National Bank first reported a position in XBI in Q1 2024 and has held it in 10 quarters since. The position peaked at $7.91K in Q2 2026. 115 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

Hilltop National Bank held 50 shares of State Street SPDR S&P Biotech ETF worth $7.88K as of Q3 2026.
Hilltop National Bank left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
State Street SPDR S&P Biotech ETF made up ﹤0.01% of Hilltop National Bank's portfolio in Q3 2026, its #670 holding.
Hilltop National Bank first reported a position in State Street SPDR S&P Biotech ETF in Q1 2024 and has held it in 10 quarters since.
Hilltop National Bank's State Street SPDR S&P Biotech ETF position peaked at $7.91K in Q2 2026.
115 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Hilltop National Bank's 13F filing for Q3 2026, filed 14 Oct 2026.